Nicholas Potter

💰 UK-based Hesta Health has launched with £2 million in pre-seed funding to build a healthcare platform focused on women’s health, starting with comprehensive postnatal support. The oversubscribed round was led by Eka Ventures, with participation from Blue Lion Capital L P, Ascension Ventures, Samos Investments, and angel investors. The company was co-founded by Dr Sujitha Selvarajah and Amanda Cupples. Dr. Selvarajah is an NHS Obstetrics & Gynaecology doctor with experience in global public health and research at University of Oxford and UCL. Cupples is a former Managing Director of Northern Europe & MEA at Airbnb and CCO/COO of BABYLON HEALTHCARE SERVICES LIMITED. 🚀 💬 “We tell women to advocate for themselves — to speak up, push harder, demand more. And we absolutely should. But what if we built a healthcare system that worked for every woman in the first place? After birth, women’s health needs can increase, just as the system’s ability to meet them falls away.” Dr Sujitha Selvarajah, Co-Founder of Hesta Health 👉 Full story: https://lnkd.in/gJxYAnqa #femtech #womenshealth #womenshealthinnovation #healthtech #healthcareinnovation #maternalhealth #postpartum #uk #investment #startup #preseed #vc #venturecapital

148

4 Comments

The Medical Travel Company (TMTC) has raised €3.8 million in funding to scale its cross-border medical travel platform connecting UK patients with affordable, high-quality treatments in India. The round was led by Nexus Venture Partners, with participation from 4CAST, a sports-focused investment group co-founded by England cricket stars Ben Stokes and Jofra Archer, alongside Indian cricketer KL Rahul. 𝗥𝗘𝗔𝗗 𝗧𝗛𝗘 𝗗𝗘𝗧𝗔𝗜𝗟𝗦 👉 https://lnkd.in/dQ_iQ33p Dhruvil Sanghvi Pratik Poddar Sam Shah Tanu Mehta Nadia Ahmed Sahil Jain Ankur Gupta Himanshu Seth Ankit Mehrotra, CFA Garima Titoria Kritvi Methi Sukhdev Singh Shivam Jha Anuj Kumar Andrew Smith Karan Godinho Pushpender Singh Snigdhaa Ghai Anamika Sikri Radhika Sarin Dr. Sukalpa Rathore Shrikant Sharma Paras Dua #Startups #HealthCare #Founders #FundingNews #VentureCapital

50

10 Comments

Our Chief Executive Birju Bartoli was recently interviewed by Eleanor Hayward, Health Editor at The Times. The piece focused around how Northumbria Healthcare NHS Foundation Trust achieves success, through prioritising the health and wellbeing of staff, as well as patients. “When we talk about looking after our own, we absolutely mean it,” explains Dr Birju Bartoli. “We all live on the patch. You have generations of the same family who work here — grandparents, mothers, sons.” It highlights how our staff follow a mantra that “patients’ time is precious”, and it’s evident from the moment someone turns up at A&E. Some 150 patients per day walk through the front door at the emergency care hospital in Cramlington. But a unique “streaming” system — a form of triaging — means only about one in three end up seated in the A&E waiting room. Patients are assessed straight away by an emergency specialist in the hospital foyer, who — wherever possible — books them in for treatment elsewhere. This might mean going straight to an operating theatre to have their appendix removed, or being booked for an x-ray for a sprained ankle at an urgent treatment centre. Others are directed back home, or to their GP or pharmacy, after being reassured nothing is seriously wrong. “We have had people at the front door with a cut finger where we say — ‘you need to go to a pharmacy and buy a plaster’,” said Dr Sameer Sasidharan, an A&E consultant, stressing that it is understandable why worried people come as “A&E is the only place that is open 24/7”. This is the first A&E department in the country to link up directly with community services, aiming to ensure people “don’t bounce around in the system” between GPs and hospitals. Dr Julian Coffey, head of urgent care at Northumbria, explained: “It is about getting patients to the right place as quickly as possible,” so they do not face delays or have unnecessary [and expensive] tests. One classic example is chest pain. “It is very common and the first worry of everyone is that it could be a heart attack, so they come to A&E,” Coffey said. “However, we send home the vast majority. Often it is anxiety or stress, or they’ve pulled a muscle. If the patient can be told really rapidly that they’re OK, that is so valuable for them.” If you are subscribed, you can read the full article on The Times website.

159

5 Comments

Since 2020, Skin Analytics has provided Bupa Members with remote skin cancer assessments – five years on, and our partnership is expanding 🤝 Bupa members can now access quick and convenient support for a wider range of everyday skin conditions such as rashes, dryness or irritation or suspected skin conditions like psoriasis, eczema and hives. Dr Timothy Woodman, Medical Director for Policy and Cancer Services at Bupa, said: “By ensuring our customers have timely access to convenient and reliable dermatology care, our expanded remote pathway is helping people to understand their skin issues quickly, stay healthy, and increase capacity for specialist consultants to support the most complex cases.” Read more about our work with Bupa in Health & Protection ⬇️ 👉 https://lnkd.in/en4WDUFX

88

4 Comments

🚀 We've been featured in The Times! The article quotes our CEO and Co-Founder Professor Sir Peter Donnelly discussing our Health Insights test, which is available through several healthcare providers, including Bupa. Health Insights UK is the first UKCA-marked and MHRA-registered product that combines genetic and clinical factors to predict an individual's risk of common diseases. The test currently includes heart disease, type 2 diabetes and prostate or breast cancer. Peter said, “These are diseases that cause the most sickness in our populations. They use 70 or 80 per cent of healthcare budgets, and they’re responsible for most of the premature mortality that we have. That’s a huge change.” Our test is based on polygenic risk scores (PRS), which use algorithms to combine information from millions of places in an individual's DNA to give a summary of their genetic susceptibility to a disease. With this information, people can make more informed decisions about their health, helping shift healthcare from reactive treatment to proactive prevention. As Peter emphasised, this is the future of medicine.🧬 👉Read the article here to find out more: https://lnkd.in/egwtXNdV #Genomics #TheTimes #PrecisionMedicine #TechBio #prevention #healthcare 

106

Peter Rudd-Clarke and Kate Davies unpack the NHS Long Term Plan - “buy once, roll out” frameworks, a shift to value‑based procurement, and practical bid tips. On clinical trials, they cover a single national standardised contract across NHS sites, streamlined “one‑and‑done” evidence submissions, and risk‑based UK rules due next April to speed study start‑up and boost participation. Listen to the full episode here: https://lnkd.in/ernNpejk The bold vision for a more efficient, innovative and fully digital NHS will rely heavily on the private sector. Read our full Insight exploring this topic in more detail: https://lnkd.in/e3Pzmvxw #OCHealthCheck #DigitalHealth #NHS

31

What does population health really mean—and why should Life Sciences care? In the latest episode of Making Market Access Real, Jim McArdle is joined by Matt Kearney and Adam Chapman to unpack the critical role Life Sciences can play in supporting the NHS to deliver real change. Watch the full video here: https://bit.ly/3IPCwwN

27